Hardcover(2nd ed. 2018)

$130.80 $139.99 Save 7% Current price is $130.8, Original price is $139.99. You Save 7%.

Product Details

ISBN-13: 9783319629407
Publisher: Springer International Publishing
Publication date: 11/12/2017
Series: Molecular Pathology Library
Edition description: 2nd ed. 2018
Pages: 296
Product dimensions: 6.10(w) x 9.25(h) x (d)

About the Author

Philip T. Cagle, MD

Houston Methodist Hospital

Department of Pathology & Genomic Medicine

6565 Fannin St

Houston, TX 77030


Timothy C. Allen, MD

The University of Texas Medical Branch

Department of Pathology

301 University Boulevard

Galveston, TX 77555


Mary Beth Beasley, MD

Mount Sinai Hospital

Department of Pathology

1468 Madison Avenue

New York, NY 10029


Lucian R. Chirieac, MD

Brigham And Women's Hospital

Department of Pathology

75 Francis St.

Boston, MA 02115


Sanja Dacic, MD, PhD

University of Pittsburgh Medical Center

Department of Pathology

200 Lothrop St.

Pittsburgh, PA 15213


Alain C. Borczuk, MD

Weill Cornell University Medical Center

Department of Pathology

1300 York Avenue

Starr-1000A

New York, NY 10065


Keith M. Kerr, MD

Aberdeen University Medical School

Aberdeen Royal Infirmary

Department of Pathology

Foresterhill

Aberdeen, Scotland


Lynette Sholl, MD

Brigham And Women's Hospital

Department of Pathology

75 Francis St

Boston, MA 02115


Bryce Portier, MD

Houston Methodist Hospital

Department of Pathology & Genomic Medicine

6565 Fannin St

Houston, TX 77030


Eric Bern

icker, MD

Houston Methodist Hospital

Thoracic Medical Oncology

6445 Main St, Floor 21

Houston, TX 77030

Table of Contents

I. Background

1. Precision Medicine of Lung Cancer: Introduction
2. Lung Cancer Epidemiology and Demographics
3. Genetic Susceptibility to Lung Cancer
4. Lung Cancer Stem Cells
5. The 2015 World Health Organization Classification of Lung Cancer: Overview

II. Testing Methods

6. Preanalytic considerations
7. Mutation testing of lung cancer biomarkers
8. Translocation testing of lung cancer biomarkers
9. Immunohistochemistry of lung cancer biomarkers
10. Next Generation and Third Generation Sequencing of lung cancer biomarkers

III. Molecular Pathology of Specific Cell Types

11. Mutations as Predictive Biomarkers for Adenocarcinoma
12. Translocations as predictive Biomarkers for Adenocarcinoma
13. Predictive Biomarkers for Squamous Cell Carcinoma
14. Molecular Pathology of Small Cell Carcinoma
15. Molecular Pathology of Uncommon Carcinomas
16. Molecular Pathology of Lung Cancer Metastases
17. Molecular Pathology of Precursor and Preinvasive Lesions

IV. General and Emerging Fields in Molecular Pathology of Lung Cancer

18. Prognostic biomarkers in lung cancer
19. Biomarkers and Differing Therapy Modalities
20. Immuno-oncology of Lung Cancer
21. Liquid Biopsy.

Customer Reviews

Most Helpful Customer Reviews

See All Customer Reviews